© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
First FDA approved treatment for thyroid eye disease
The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid eye disease (TED).
TED is a rare disorder which causes the...
Poor diet increases risk for late-stage age-related macular degeneration
A new study from the British Journal of Ophthalmology has revealed a link between poor diet and the increased risk of age-related macular degeneration (AMD). AMD is irreversible and affects the central vision, impacting...